Alleviation of palmitic acid-induced endoplasmic reticulum stress by augmenter of liver regeneration through IP3R-controlled Ca2+ release

被引:23
作者
Xiao, Wei-chun
Zhang, Jing
Chen, Si-li
Shi, Yi-jun
Xiao, Fan
An, Wei [1 ]
机构
[1] Capital Med Univ, Dept Cell Biol, 10 You An Men Wai Xi Tou Tiao, Beijing 100069, Peoples R China
基金
中国国家自然科学基金;
关键词
augmenter of liver regeneration; BCL-2; endoplasmic reticulum stress; inositol-1; 4; 5-trisphosphate receptor; non-alcoholic steatohepatitis; ER; MEMBRANE; RECEPTOR; PROTEIN; IDENTIFICATION;
D O I
10.1002/jcp.26463
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The aberrant release of Ca2+ from the endoplasmic reticulum (ER) contributes to the onset of ER stress, which is closely related to the pathogenesis of non-alcoholic fatty liver disease. We previously reported that augmenter of liver regeneration (ALR) alleviates ER stress and protects hepatocytes from lipotoxicity. However, the link between ALR protection and the suppression of ER stress remains unclear. In this study, we investigated whether the protection against liver steatosis afforded by ALR is related to its inhibition of calcium overflow from the ER to the mitochondria. The treatment of HepG2 cells with palmitic acid (PA) upregulated IP3R expression, triggering ER-luminal Ca2+ release and inducing ER stress. However, in ALR-transfected (ALR-Tx) HepG2 cells, PA-induced cell injury was clearly alleviated compared with that in vector-Tx cells. After exposure to PA, IP3R expression was downregulated and ER stress was effectively inhibited in the ALR-Tx cells, and ER-Ca2+ release and simultaneous mitochondrial Ca2+ uptake were lower than those in vector-Tx cells. The knockdown of ALR expression with shRNA abolished the protective effects afforded by ALR transfection. PA treatment also suppressed the interaction between BCL-2 and IP3R in HepG2 cells, whereas this interaction was massively enhanced in the ALR-Tx cells, effectively reducing the IP3R-mediated ER-Ca2+ release and thus mitochondrial Ca2+ influx. Our results suggest that the inhibition of ER stress by ALR is related to the interruption of the interaction between BCL2 and IP3R, demonstrating a novel mechanism of ER stress resistance in ALR-Tx cells.
引用
收藏
页码:6148 / 6157
页数:10
相关论文
共 35 条
  • [1] Endoplasmic Reticulum Stress and Lipid Metabolism: Mechanisms and Therapeutic Potential
    Basseri, Sana
    Austin, Richard C.
    [J]. BIOCHEMISTRY RESEARCH INTERNATIONAL, 2012, 2012
  • [2] INOSITOL TRISPHOSPHATE AND CALCIUM SIGNALING
    BERRIDGE, MJ
    [J]. NATURE, 1993, 361 (6410) : 315 - 325
  • [3] Identification of PTEN at the ER and MAMs and its regulation of Ca2+ signaling and apoptosis in a protein phosphatase-dependent manner
    Bononi, A.
    Bonora, M.
    Marchi, S.
    Missiroli, S.
    Poletti, F.
    Giorgi, C.
    Pandolfi, P. P.
    Pinton, P.
    [J]. CELL DEATH AND DIFFERENTIATION, 2013, 20 (12) : 1631 - 1643
  • [4] Structural and functional features and significance of the physical linkage between ER and mitochondria
    Csordas, Gyorgy
    Renken, Christian
    Varnai, Peter
    Walter, Ludivine
    Weaver, David
    Buttle, Karolyn F.
    Balla, Tamas
    Mannella, Carmen A.
    Hajnoczky, Gyorgy
    [J]. JOURNAL OF CELL BIOLOGY, 2006, 174 (07) : 915 - 921
  • [5] The Contribution of Endoplasmic Reticulum Stress to Liver Diseases
    Dara, Lily
    Ji, Cheng
    Kaplowitz, Neil
    [J]. HEPATOLOGY, 2011, 53 (05) : 1752 - 1763
  • [6] Regulation of polyamine synthesis in human hepatocytes by hepatotrophic factor augmenter of liver regeneration
    Dayoub, Rania
    Thasler, Wolfgang E.
    Bosserhoff, Anja K.
    Singer, Thomas
    Jauch, Karl-Walter
    Schlitt, Hans J.
    Weiss, Thomas S.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 345 (01) : 181 - 187
  • [7] ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload
    Egnatchik, Robert A.
    Leamy, Alexandra K.
    Jacobson, David A.
    Shiota, Masakazu
    Young, Jamey D.
    [J]. MOLECULAR METABOLISM, 2014, 3 (05): : 544 - 553
  • [8] Non-Alcoholic Fatty Liver Disease
    Engin, Atilla
    [J]. OBESITY AND LIPOTOXICITY, 2017, 960 : 443 - 467
  • [9] Nonalcoholic fatty liver disease: From steatosis to cirrhosis
    Farrell, GC
    Larter, CZ
    [J]. HEPATOLOGY, 2006, 43 (02) : S99 - S112
  • [10] Festi D, 2004, Obes Rev, V5, P27, DOI 10.1111/j.1467-789X.2004.00126.x